| |
|
Form Serial Number: |
DA20220915E00241
|
| 1.
Date of relevant event: |
13/09/2022
(dd/mm/yyyy)
|
| 2.
Date when director became aware of the relevant event/ interest in the shares (if later): |
(dd/mm/yyyy)
|
| 3.
Stock code: |
02157 |
| 4.
Name of listed corporation: |
Lepu Biopharma Co., Ltd. - B - H Shares |
| 5.
Class of shares: |
H Shares |
| 6.
Number of issued shares in class: |
1,605,176,474 |
| 7.
Name of director (English) as printed on HKID Card/Passport: |
| (Surname) |
Lin |
| (Other names) |
Xianghong |
|
|
|
| 10.
Name of director (Chinese): |
林向紅 |
| 11.
Chinese Character Code as printed on HKID Card: |
|
| |
| 24.
Details of relevant event: |
|
|
Brief description of relevant event
|
Capacity in which shares were/are held
|
Number of shares bought/sold or involved
|
Currency of transaction |
On Exchange
|
Off Exchange
|
|
Before relevant event
|
After relevant event
|
Highest price (per share)
|
Average price (per share)
|
Average consideration (per share)
|
Consideration code
|
| Long position |
| 1201 | The number of shares in which you are interested has reduced because:
you completed a sale of the shares |
|
| 2305 | Beneficiary of a trust (other than a discretionary interest) |
|
| 2305 | Beneficiary of a trust (other than a discretionary interest) |
|
356,000 |
HKD |
14.2674 |
14.2674 |
|
|
| Short position |
|
|
|
|
|
|
|
|
|
| |
|
| 25.
Total shares in listed corporation immediately before the relevant event: |
| | Total number of shares | Percentage figure (%) |
| Long position | 21,859,000 | 1.36 |
|
| |
| 26.
Total shares in listed corporation immediately after the relevant event: |
| | Total number of shares | Percentage figure (%) |
| Long position | 21,503,000 | 1.34 |
|
| |
| 27.
Capacity in which interests disclosed in Box 26 are held: |
| Code describing capacity | Number of shares |
| 2305 | Beneficiary of a trust (other than a discretionary interest) |
| |
|
| |
| 28.
Further information in derivative interests in listed corporation : |
| Derivatives code |
Exercise period (dd/mm/yyyy) |
Consideration - if derivatives granted by listed corporation |
Number of shares |
| | | Begins | Ends | Currency | Price for grant | Currency | Exercise price | Currency | Price on assignment | |
| | | | | | | | | | | |
|
| |
| 29.
Further information in relation to interests of children under 18 and/or spouse: |
| Child/Spouse | Name of child/spouse | Number of shares |
| | |
|
| |
| 30.
Further information in relation to interests of corporations controlled by Director: |
| Name of controlled corporation | Address and place of incorporation | Name of controlling person | % control | Direct interest (Y/N) | Number of shares |
| Ace Treasure Enterprise Limited | Vistra Corporate Services Centre, Wickhams Cay II, Road Town Tortola, VG1110 , British Virgin Islands | Ace Treasure Trust | 100.00 | N | |
| Superb Outcome Limited | Vistra Corporate Services Centre, Wickhams Cay II, Road Town Tortola, VG1110 , British Virgin Islands | Superb Outcome Trust | 100.00 | N | |
| King Star Med Management Limited | Maples Corporate Services Limited, PO Box 309, Ugland House, Grand Cayman Islands, KY1-1104, Cayman Islands | Ace Treasure Enterprise Limited | 40.00 | N | |
| King Star Med Management Limited | Maples Corporate Services Limited, PO Box 309, Ugland House, Grand Cayman Islands, KY1-1104, Cayman Islands | Superb Outcome Trust | 30.00 | N | |
| King Star Consulting Limited | Maples Corporate Services Limited, PO Box 309, Ugland House, Grand Cayman Islands, KY1-1104, Cayman Islands | Ace Treasure Enterprise Limited | 40.00 | N | |
| King Star Consulting Limited | Maples Corporate Services Limited, PO Box 309, Ugland House, Grand Cayman Islands, KY1-1104, Cayman Islands | Superb Outcome Trust | 30.00 | N | |
| King Star Med LP | Maples Corporate Services Limited, PO Box 309, Ugland House, Grand Cayman Islands, KY1-1104, Cayman Islands | King Star Med Management Limited/ King Star Consulting Limited | 100.00 | Y | |
|
| |
| 31.
Further information in relation to interests held by Director jointly with another person: |
| Name of joint shareholder | Address | Number of shares |
| | |
|
| |
| 32.
Further information from a director who is a trustee, or beneficiary of a trust, or a person who has set up a Discretionary Trust: |
| Names of Trust | Address | Status code | Number of shares |
| Ace Treasure Trust | Addresses of individuals are not displayed. | | 5102 | Beneficiary of a trust (other than a discretionary interest) |
| |
| Superb Outcome Trust | Addresses of individuals are not displayed. | | 5102 | Beneficiary of a trust (other than a discretionary interest) |
| |
|
| |
| 33.
Further information from a party to an agreement under Section 317 (Please see Notes for further information required): |
| Names of other parties | Address | Number of shares |
| | |
| Total number of shares in which a director is interested under sections 317 and 318 | |
|
| |
| 34.
Supplementary information: |
Lin Xianghong is the settlor, protector, one of the beneficiaries of the Ace Treasure Trust and Superb Outcome Trust, and therefore controls 70% interest of the King Star Med LP's general partner and manager (King Star Med Management Limited and King Star Consulting Limited).
|
| 35.
Log/Serial Number of the previous form: |
|
| 36.
Number of concert party document(s) under section 317 attached/uploaded: |
|
|
Date of filing this Form 3A: |
15/09/2022
(dd/mm/yyyy)
|
| |